Centene shares plummet as it withdraws full-year guidance
Centene Corp (NYSE:CNC) shares fell almost 40% after the healthcare company withdrew its full-year 2025 financial guidance due to weak growth and higher-than-expected costs in its Affordable Care Act (ACA) marketplace business. Based on a preliminary analysis from the independent actuarial firm Wakely, Centene anticipates a $1.8 billion shortfall in risk adjustment revenue for 2025, which translates to a $2.75 per share reduction in adjusted earnings.
Centene Pulls 2025 Guidance as Marketplace Growth Falters
CNC pulls its 2025 forecast after a $1.8B risk adjustment shortfall. Also, weak Marketplace growth shakes investor confidence.
Is Centene (CNC) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Low Price-to-Book Value Stocks to Buy in July for Solid Returns
The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, ODP, STNE and PSFE are some such stocks.
Centene's Medicaid business and healthcare costs are a problem, and its stock plunges
Centene's stock suffers a historic plunge as underestimation of healthcare costs leads the insurer to withdraw its full-year earnings outlook.
Centene: Is The 25% Fall In CNC Stock Justified?
Centene Corporation (NYSE:CNC) experienced a challenging Tuesday evening, witnessing a 25% drop in shares during after-hours trading on July 1st. The significant decline in the healthcare giant's stock wasn't merely another example of market fluctuations; it was directly sparked by the company's complete withdrawal of its 2025 guidance, creating turmoil among investors.
Centene Stock Plummets 27%. What Sparked the Brutal Selloff.
It's been a tough year for health insurance stocks, with UnitedHealth also tumbling after the company pulled its guidance.
Centene Latest Insurer Facing Higher Costs As GOP Preps Bigger Hit
News government-subsidized health insurance provider Centene is withdrawing its 2025 financial guidance comes as the Republican-controlled Congress is poised to slash hundreds of billions of dollars in funding to Medicaid and Obamacare markets largely administered by health insurers.
Facing Slower Growth, Health Insurer Centene Pulls 2025 Profit Outlook
Health insurer Centene, one of the nation's biggest providers of individual coverage under the Affordable Care Act known as Obamacare, on Tuesday withdrew its 2025 guidance, saying market growth in more than 20 states is lower than expected.
Centene withdraws 2025 forecast after review of marketplace risk adjustment
U.S. health insurer Centene said on Tuesday it has withdrawn its 2025 earnings forecast, sending its shares down nearly 22% in extended trading.
Centene (CNC) Loses 5.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Centene (CNC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks
Top-ranked stocks Centene (CNC), Astera Labs Inc. (ALAB), Five9 (FIVN), Uber Technologies (UBER) and Voya Financial (VOYA) are likely to beat on the bottom line in their upcoming releases.
